Stenotrophomonas maltophilia ocular infections

Archives of Ophthalmology
R L Penland, K R Wilhelmus

Abstract

To determine if the number of ocular infections associated with Stenotrophomonas maltophilia is increasing, to identify predisposing factors, and to evaluate antimicrobial susceptibility. Retrospective review of ocular microbiology laboratory records from January 1, 1972, through December 31, 1995. Stenotrophomonas maltophilia was recovered from 15 cases of ocular infection, at a rate of one in every 1339 ocular specimens in the 1970s, one in 413 in the 1980s, and one in 363 in the 1990s through 1995. The organism was the predominant isolate in five cases and was part of a polybacterial infection in the remaining 10 cases. Eight of the 15 cases had bacterial keratitis, including one with infectious crystalline keratopathy. Of the remaining seven infections, S maltophilia was recovered from two cases of acute conjunctivitis, two infected scleral buckles (one with orbital cellulitis), two cases of infantile dacryocystitis, and one case of preseptal cellulitis. Ocular isolates of S maltophilia were resistant to the aminoglycosides and most beta-lactams, and showed variable susceptibility to the fluoroquinolones. Stenotrophomonas maltophilia is emerging as an important opportunistic ocular pathogen. Most infections by this organism...Continue Reading

Citations

Mar 27, 2012·Indian Journal of Ophthalmology·Padmamalini MahendradasRohit Shetty
Sep 27, 2002·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Femida KheraniMichael D Wagoner
Jul 14, 2011·Clinical Ophthalmology·A BarsamHd Perry
Jan 11, 2012·Clinical Microbiology Reviews·Joanna S Brooke
May 1, 1997·Australian and New Zealand Journal of Ophthalmology·B A CowellR P Schneider
Feb 13, 2010·Japanese Journal of Ophthalmology·Pinnita PrabhasawatChareenun Chirapapaisan
Feb 19, 2009·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M E FalagasG Dimopoulos
Dec 19, 2007·Ocular Immunology and Inflammation·David T L LiuDennis S C Lam
Dec 17, 2015·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Tai Jun KimWon Ryang Wee
Jan 25, 2008·Cornea·Jerome C Ramos-Esteban, Bennie H Jeng
Apr 21, 2011·Expert Review of Anti-infective Therapy·Iain J AbbottLeon J Worth
Dec 26, 2012·Eye & Contact Lens·Mark D P Willcox
Dec 24, 2010·Ophthalmic Plastic and Reconstructive Surgery·Edward J Wladis
May 28, 2011·Eye & Contact Lens·Karintha Holifield, Douglas R Lazzaro
Nov 30, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C A SattlerS L Kaplan
Apr 22, 2016·Cornea·An-Lun WuChing-Hsi Hsiao
Sep 16, 2004·The Korean Journal of Internal Medicine·Joo-Eun BaekSe-Ho Chang
Aug 5, 2004·Acta Ophthalmologica Scandinavica·Thiemo RudolphUlf Stenevi
Aug 25, 2020·Translational Vision Science & Technology·Alexandre Xavier da CostaJosé Alvaro Pereira Gomes
May 14, 2021·Ophthalmology and Therapy·B-C ParkJae-Woong Koh
Dec 2, 2000·Journal of Clinical Microbiology·P W WhitbyT L Stull
Mar 31, 2021·Ophthalmic Plastic and Reconstructive Surgery·Matthew HabibTal J Rubinstein
Oct 15, 2021·Scientific Reports·Tristan DaehnRobert Kromer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.